Fisher Asset Management’s Viridian Therapeutics VRDN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $7.13M | Sell |
509,959
-27,065
| -5% | -$378K | ﹤0.01% | 438 |
|
|
2025
Q1 | $7.24M | Buy |
537,024
+18,997
| +4% | +$256K | ﹤0.01% | 452 |
|
|
2024
Q4 | $9.93M | Buy |
518,027
+23,103
| +5% | +$443K | ﹤0.01% | 432 |
|
|
2024
Q3 | $11.3M | Buy |
494,924
+99,427
| +25% | +$2.26M | ﹤0.01% | 407 |
|
|
2024
Q2 | $5.15M | Buy |
395,497
+6,410
| +2% | +$83.4K | ﹤0.01% | 486 |
|
|
2024
Q1 | $6.81M | Buy |
+389,087
| New | +$6.81M | ﹤0.01% | 464 |
|